Search research articles
Contact Us
Filters
Showing results (161-170 of 268) with videos related to
Page
of 27
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 5, 2015
Treatment Response Assessment in IDH-Mutant Glioma Patients by Noninvasive 3D Functional Spectroscopic Mapping of 2-Hydroxyglutarate
Ovidiu C Andronesi, Franziska Loebel, Wolfgang Bogner, et al.
Neuro-Oncology
|
May 27, 2015
A phase I study of cediranib in combination with cilengitide in patients with recurrent glioblastoma
Elizabeth R Gerstner, Xiaobu Ye, Dan G Duda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 4, 2007
Loss of the mismatch repair protein MSH6 in human glioblastomas is associated with tumor progression during temozolomide treatment
Daniel P Cahill, Kymberly K Levine, Rebecca A Betensky, et al.
Neuro-Oncology Advances
|
September 8, 2022
Magnetic resonance spectroscopy outperforms perfusion in distinguishing between pseudoprogression and disease progression in patients with glioblastoma
Mohamed E El-Abtah, Pratik Talati, Melanie Fu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 2009
Edema control by cediranib, a vascular endothelial growth factor receptor-targeted kinase inhibitor, prolongs survival despite persistent brain tumor growth in mice
Walid S Kamoun, Carsten D Ley, Christian T Farrar, et al.
Cancer
|
March 17, 2020
Primary dural lymphomas: Clinical presentation, management, and outcome
Philipp Karschnia, Tracy T Batchelor, Justin T Jordan, et al.
Neuro-Oncology Advances
|
January 4, 2021
Vascular dysfunction promotes regional hypoxia after bevacizumab therapy in recurrent glioblastoma patients
Elizabeth R Gerstner, Kyrre E Emblem, Yi-Fen Yen, et al.
Journal of Oncology Practice
|
January 26, 2019
Performance of a Hospital Pathway for Patients With a New Single Brain Mass
Isabel Arrillaga-Romany, William T Curry, Justin T Jordan, et al.
Neuro-Oncology
|
November 30, 2018
Financially effective test algorithm to identify an aggressive, EGFR-amplified variant of IDH-wildtype, lower-grade diffuse glioma
Tejus A Bale, Justin T Jordan, Otto Rapalino, et al.
Blood
|
July 2, 2008
CNS Hodgkin lymphoma
Elizabeth R Gerstner, Lauren E Abrey, David Schiff, et al.
Page
of 27
Search research articles
Search
Showing results (161-170 of 268) with videos related to
Sort By:
Page
of 27
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 5, 2015
Treatment Response Assessment in IDH-Mutant Glioma Patients by Noninvasive 3D Functional Spectroscopic Mapping of 2-Hydroxyglutarate
Ovidiu C Andronesi, Franziska Loebel, Wolfgang Bogner, et al.
Neuro-Oncology
|
May 27, 2015
A phase I study of cediranib in combination with cilengitide in patients with recurrent glioblastoma
Elizabeth R Gerstner, Xiaobu Ye, Dan G Duda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 4, 2007
Loss of the mismatch repair protein MSH6 in human glioblastomas is associated with tumor progression during temozolomide treatment
Daniel P Cahill, Kymberly K Levine, Rebecca A Betensky, et al.
Neuro-Oncology Advances
|
September 8, 2022
Magnetic resonance spectroscopy outperforms perfusion in distinguishing between pseudoprogression and disease progression in patients with glioblastoma
Mohamed E El-Abtah, Pratik Talati, Melanie Fu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 2009
Edema control by cediranib, a vascular endothelial growth factor receptor-targeted kinase inhibitor, prolongs survival despite persistent brain tumor growth in mice
Walid S Kamoun, Carsten D Ley, Christian T Farrar, et al.
Cancer
|
March 17, 2020
Primary dural lymphomas: Clinical presentation, management, and outcome
Philipp Karschnia, Tracy T Batchelor, Justin T Jordan, et al.
Neuro-Oncology Advances
|
January 4, 2021
Vascular dysfunction promotes regional hypoxia after bevacizumab therapy in recurrent glioblastoma patients
Elizabeth R Gerstner, Kyrre E Emblem, Yi-Fen Yen, et al.
Journal of Oncology Practice
|
January 26, 2019
Performance of a Hospital Pathway for Patients With a New Single Brain Mass
Isabel Arrillaga-Romany, William T Curry, Justin T Jordan, et al.
Neuro-Oncology
|
November 30, 2018
Financially effective test algorithm to identify an aggressive, EGFR-amplified variant of IDH-wildtype, lower-grade diffuse glioma
Tejus A Bale, Justin T Jordan, Otto Rapalino, et al.
Blood
|
July 2, 2008
CNS Hodgkin lymphoma
Elizabeth R Gerstner, Lauren E Abrey, David Schiff, et al.
Page
of 27